60 DEGREES PHARMACEUTICALS, INC. Conversion of Stock, Shares Converted
60 DEGREES PHARMACEUTICALS, INC. (SXTP) reported Conversion of Stock, Shares Converted of 1.33 thousand shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2026-08-14
- 60 DEGREES PHARMACEUTICALS, INC. conversion of stock, shares converted for the quarter ending 2024-12-31 was -5.33K shares.
- 60 DEGREES PHARMACEUTICALS, INC. conversion of stock, shares converted for the quarter ending 2024-09-30 was 0.00 shares.
- 60 DEGREES PHARMACEUTICALS, INC. conversion of stock, shares converted for the quarter ending 2024-06-30 was -73.27K shares.
- 60 DEGREES PHARMACEUTICALS, INC. conversion of stock, shares converted for the quarter ending 2024-03-31 was 79.93K shares, a 92.79% decline year-over-year.
- 60 DEGREES PHARMACEUTICALS, INC. conversion of stock, shares converted for fiscal 2024 was 1.33K shares, a 98.33% decline from fiscal 2023.
- 60 DEGREES PHARMACEUTICALS, INC. conversion of stock, shares converted for fiscal 2023 was 79.93K shares.
| Period end | Conversion of Stock, Shares Converted 0 month | Conversion of Stock, Shares Converted | Conversion of Stock, Shares Converted as first filed | Conversion of Stock, Shares Converted 1 month | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -5.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -5.33K shares derived: sum of 2 quarters · filed 2025-03-27 | -78.59K shares derived: sum of 3 quarters · filed 2025-03-27 | 1.33K shares 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -73.27K shares derived: sum of 2 quarters · filed 2024-11-14 | 6.66K shares 10-Q · filed 2024-11-14 | |||||
| 2024-06-30 | -73.27K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 6.66K shares 10-Q · filed 2024-08-14 | ||||||
| 2024-03-31 | 79.93K shares 10-Q · filed 2024-05-15 | |||||||
| 2023-12-31 | 79.93K shares 10-K · filed 2024-04-01 | |||||||
| 2023-03-31 | 1.11M shares 10-Q · filed 2023-08-25 | |||||||
| 2022-03-31 | 214.93K shares 10-Q · filed 2023-11-20 | 4.62K shares 10-Q · filed 2026-08-14 | 1.11M shares 10-Q · filed 2024-05-15 | 214.93K shares 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |